特应性皮炎（Atopic Dermatitis, AD）是一种令人困扰的慢性皮肤病，很多人可能会问：它究竟是什么病？为何有些人在公共场合也无法控制瘙痒？面对中重度特应性皮炎的患者，他们的生活又是怎样的？ 特应性皮炎的病因复杂，主要与皮肤屏障功能受损、免疫系统失调以及神经系统相互作用有关。根据复旦大学附属华山医院的顾超颖教授，特应性皮炎是一种复发性炎症性疾病，全球有超过2.3亿人受到其影响。在中国， ...

Dupixent shows potential as a treatment for atopic dermatitis, alopecia and vitiligo, targeting shared immune pathways for ...

Jiangsu Vcare Pharmatech Co., Ltd. (Jiangsu Vcare) announced that it has entered into an exclusive strategic partnership with ...

Severe atopic dermatitis affects at least 30 percent of the body. The size of your child’s palm is about 1 percent, he explains, so if there are 10 areas the size of their palm affected, your ...

Integrative approaches targeting neurological and immune pathways may help break the itch–scratch cycle in atopic dermatitis, improving pruritus, stress, sleep, and patient outcomes.

Apogee Therapeutics recently reported positive 16-week results from its APEX Phase 2 Part A trial, with APG777 meeting all primary and key secondary endpoints in moderate-to-severe atopic dermatitis ...

Children with moderate/more extensive atopic dermatitis treated with ruxolitinib cream achieved significant disease control ...

Incyte Corporation (($CC:INCY.CUR)) announced an update on their ongoing clinical study. Incyte Corporation is conducting a Phase 3b clinical ...

Atopic dermatitis (AD), the most common form of eczema, is a chronic inflammatory disease that results in itchy, red, and irritated skin. From newborns to adults, nearly 18 million people in the ...

LAWRENCEVILLE, N.J.--(BUSINESS WIRE)--Asana BioSciences announced today positive topline results from a Phase 1b study evaluating the treatment of pruritus associated with atopic dermatitis ...